Charles Schwab’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.31M | Buy |
|
|||||
|
2025
Q2 | $647K | Buy |
|
|||||
|
2025
Q1 | $95.3K | Hold |
|
|||||
|
2024
Q4 | $160K | Buy |
|
|||||
|
2024
Q3 | $82.7K | Hold |
|
|||||
|
2024
Q2 | $28.5K | Hold |
|
|||||
|
2024
Q1 | $27.9K | Hold |
|
|||||
|
2023
Q4 | $27.6K | Hold |
|
|||||
|
2023
Q3 | $22.9K | Hold |
|
|||||
|
2023
Q2 | $35.9K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $28K | Hold |
|
|||||
|
2021
Q3 | $55K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $43K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $146K | Buy |
|
|||||
|
2018
Q4 | $96K | Hold |
|
|||||
|
2018
Q3 | $223K | Hold |
|
|||||
|
2018
Q2 | $285K | Buy |
|
|||||
|
2018
Q1 | $202K | Hold |
|
|||||
|
2017
Q4 | $182K | Hold |
|
|||||
|
2017
Q3 | $279K | Hold |
|
|||||
|
2017
Q2 | $212K | Buy |
|